Functional interaction between CTGF and FPRL1 regulates VEGF-A-induced angiogenesis

Cellular Signalling

Volumn 27, Issue 7, 2015, Pages 1439-1448

  Lee, Mi Sook ^a   Ghim, Jaewang ^a   Kim, Sun Jin ^a   Yun, Young Sung ^a   Yoo, Seung Ah ^b   Suh, Pann Ghill ^a   Kim, Wan Uk ^b   Ryu, Sung Ho ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Connective tissue growth factor; Formyl peptide receptor like 1; Vascular endothelial growth factor A; WRW4

Indexed keywords

CALCIUM; CELL PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; MITOGEN ACTIVATED PROTEIN KINASE; VASCULOTROPIN A; FORMYLPEPTIDE RECEPTOR; FPR2 PROTEIN, HUMAN; LIPOXIN RECEPTOR; PROTEIN BINDING; RECOMBINANT PROTEIN; SMALL INTERFERING RNA;

ANGIOGENESIS; ARTICLE; CALCIUM CELL LEVEL; CELL FUNCTION; CELL MIGRATION; CHORIOALLANTOIS; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UMBILICAL VEIN ENDOTHELIAL CELL; AMINO ACID SEQUENCE; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; RNA INTERFERENCE;

AMINO ACID SEQUENCE; CONNECTIVE TISSUE GROWTH FACTOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84928380185     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2015.04.001     Document Type: Article

References (36)

1. Coultas L., Chawengsaksophak K., Rossant J. Nature 2005, 438:937-945.
2. Santulli G. Angiogenesis: Insights from a Systematic Overview 2013, Nova Biomedical, Hauppauge New York.
3. Eichmann A., Simons M. Curr. Opin. Cell Biol. 2012, 24:188-193.
4. Lohela M., Bry M., Tammela T., Alitalo K. Curr. Opin. Cell Biol. 2009, 21:154-165.
5. Olsson A.K., Dimberg A., Kreuger J., Claesson-Welsh L. Mol. Cell. Biol. 2006, 7:359-371.
6. Natarajan K., Berk B.C. Methods Mol. Biol. 2006, 332:51-77.
7. Spiegel S., Milstien S. Nat. Rev. Mol. Cell Biol. 2003, 4:397-407.
8. Le Y., Murphy P.M., Wang J.M. Trends Immunol. 2002, 23:541-548.
9. Migeotte I., Communi D., Parmentier M. Cytokine Growth Factor Rev. 2006, 17:501-519.
10. Ying G., Iribarren P., Zhou Y., Gong W., Zhang N., Yu Z.X., Le Y., Cui Y., Wang J.M. J. Immunol. 2004, 172:7078-7085.
11. Devchand P.R., Arita M., Hong S., Bannenberg G., Moussignac R.L., Gronert K., Serhan C.N. FASEB J. 2003, 17:652-659.
12. Koczulla R., Von Degenfeld G., Kupatt C., Krotz F., Zahler S., Gloe T., Issbrucker K., Unterberger P., Zaiou M., Lebherz C., Hiemstra P.S., Vogelmeier C., Gallo R.L., Clauss M., Bals R. J. Clin. Invest. 2003, 111:1665-1672.
13. Lee M.-S., Yoo S.-A., Cho C.-S., Suh P.-G., Kim W.-U., Ryu S.H. J. Immunol. 2006, 177:5585-5594.
14. He R., Sang H., Ye R.D. Blood 2003, 101:1572-1581.
15. Abreu J.G., Ketpura N.I., Reversade B., De Robertis E.M. Nat. Cell Biol. 2002, 4:599-604.
16. Lee M.-S., Moon E.-J., Lee S.-W., Kim M.S., Kim K.-W., Kim Y.-J. Cancer Res. 2001, 61:3290-3293.
17. Leask A., Abraham D.J. J. Cell Sci. 2006, 119:4803-4810.
18. Perbal B. Lancet 2004, 363:62-64.
19. Babic A.M., Chen C.-C., Lau L.F. Mol. Cell. Biol. 1999, 19:2958-2966.
20. Gao R., Brigstock D.R. J. Biol. Chem. 2004, 279:8848-8855.
21. Hoshijima M., Hattori T., Inoue M., Araki D., Hanagata H., Miyauchi A., Takigawa M. FEBS Lett. 2006, 580:1376-1382.
22. Wahab N.A., Weston B.S., Mason R.M. J. Am. Soc. Nephrol. 2005, 16:340-351.
23. Segarini P.R., Nesbitt J.E., Li D., Hays L.G., Yates J.R., Carmichael D.F. J. Biol. Chem. 2001, 276:40659-40667.
24. Inoki I., Shiomi T., Hashimoto G., Enomoto H., Nakamura H., Makino K.-i., Ikeda E., Takata S., Kobayashi K.-i., Okada Y. FASEB J. 2001, 10.1096/fj.01-0332fje.
25. Bradham D.M., Igarashi A., Potter R.L., Grotendorst G.R. J. Cell Biol. 1991, 114:1285-1294.
26. Suzuma K., Naruse K., Suzuma I., Takahara N., Ueki K., Aiello L.P., King G.L. J. Biol. Chem. 2000, 275:40725-40731.
27. Hu J.Y., Le Y., Gong W., Dunlop N.M., Gao J.L., Murphy P.M., Wang J.M. J. Leukoc. Biol. 2001, 70:155-161.
28. Chung A.S., Ferrara N. Annu. Rev. Cell Dev. Biol. 2011, 27:563-584.
29. Lau L.F. Journal of cell communication and signaling 2012, 6:121-123.
30. Liu S.C., Chuang S.M., Hsu C.J., Tsai C.H., Wang S.W., Tang C.H. Cell death & disease 2014, 5:e1485.
31. Kitamoto S., Yokoyama S., Higashi M., Yamada N., Takao S., Yonezawa S. Oncogene 2013, 32:4614-4621.
32. Hall-Glenn F., De Young R.A., Huang B.L., van Handel B., Hofmann J.J., Chen T.T., Choi A., Ong J.R., Benya P.D., Mikkola H., Iruela-Arispe M.L., Lyons K.M. PLoS One 2012, 7:e30562.
33. Prevete N., Salzano F.A., Rossi F.W., Rivellese F., Dellepiane M., Guastini L., Mora R., Marone G., Salami A., De Paulis A. J. Biol. Regul. Homeost. Agents 2011, 25:553-564.
34. Delcourt N., Bockaert J., Marin P. Trends Pharmacol. Sci. 2007, 28:602-607.
35. Ferrero E., Belloni D., Contini P., Foglieni C., Ferrero M.E., Fabbri M., Poggi A., Zocchi M.R. Blood 2003, 101:186-193.
36. R He, H Sang, RD Ye Blood 2003, 101(4):1572-1581.